OnDemand WTP Pricing Research

WHO Adopts Weakened Resolution on Drug Price Transparency | RAPS

The World Health Organization (WHO) on Tuesday adopted a resolution to urge countries to publicly share the net prices of health products and the costs of clinical trials.

The resolution, adopted after three weeks of negotiations, also calls on United Nations member countries to better facilitate the public reporting of patent status information and marketing approval status of health products, as well as to improve national capacities for open and collaborative research, especially in developing countries and low- and middle-income countries.

The WHO Director-General was also directed to analyze the availability of clinical trial data and price information, with the possibility of establishing a web-based tool to share such information to improve the transparency of markets for health products, including investments, incentives and subsidies.

The countries that proposed the resolution included: Andorra, Brazil, Egypt, Eswatini, Greece, India, Italy, Kenya, Luxembourg, Malaysia, Malta, Portugal, Russian Federation, Serbia, Slovenia, South Africa, Spain, Sri Lanka and Uganda.

Read complete article here:

WHO Adopts Weakened Resolution on Drug Price Transparency | RAPS.

Post a Comment

WP-SpamFree by Pole Position Marketing